Therapeutic Potential of Indole Derivatives: Analytical Perspectives on Their Role in Drug Discovery.

Abstract

Indole was first identified around 1869, this being an indole ring system which is a fused benzene and pyrrole ring system. Research findings illustrate that indole derivatives have gained acceptance as therapeutic agents because they contain structural versatility and access different biological targets. Scientific research has established their strong pharmaceutical properties, especially for oncology medicines because they control essential cellular processes while interrupting defective enzymatic activities of topoisomerases, kinases, and histone deacetylases. Research proves that indole-based compounds display broad antibacterial, antifungal and antiparasitic effects in addition to their cancer-fighting properties. The indole nucleus creates targeted interactions with central nervous system receptors and enzymes for visualization in neurological therapeutic delivery. Research indicates that indole derivatives provide benefits for managing anti-inflammatory responses while lowering blood pressure and diabetes markers although benefiting cardiovascular health through their ability to affect specific disease pathways. The ongoing development of structural optimization methods with synthetic improvements leads to indole compounds which surpass present treatments according to clinical trials. Structural modifications to the indole core system have been explored in recent studies to improve its pharmacological versatility. Research from 2020 to 2024, featuring indole derivatives with their potency, mechanism of action, and strategies to overcome resistance, is highlighted, with a focus on different diseases. Finds from databases such as ScienceDirect, Google Scholar, PubMed, and EMBASE are included in the analysis.